- ►annals.org [PDF] MG Shlipak, R Katz, MJ Sarnak, LF Fried, AB … - Annals of internal medicine, 2006 - Am Coll Physicians Michael G. Shlipak, MD, MPH; Ronit Katz, PhD; Mark J. Sarnak, MD; Linda F.
Fried, MD, MPH; Anne B. Newman, MD, MPH; Catherine Stehman-Breen, MD, MS;
Stephen L. Seliger, MD; Brian Kestenbaum, MD; Bruce Psaty, MD, PhD; Russell ... Cited by 138 - Related articles - BL Direct - All 6 versions
E Selvin, J Coresh, E Shahar, L Zhang, M … - Lancet Neurology, 2005 - Elsevier 10 886 participants without diabetes and 1635 participants with diabetes in the
ARIC study, who did not have cardiovascular disease, were followed up for
incident ischaemic stroke over 8–10 years. We assayed HbA 1c for all 167 ... Cited by 44 - Related articles - All 19 versions
- ►rug.nl [PDF] NG Forouhi, B Balkau, K Borch-Johnsen, J … - Diabetologia, 2006 - Springer Page 1. Diabetologia (2006) 49: 822–827 DOI 10.1007/s00125-006-0189-4 ARTICLE NG
Forouhi . B. Balkau . K. Borch-Johnsen . J. Dekker . C. Glumer . Q. Qiao . ... Cited by 32 - Related articles - BL Direct - All 6 versions
- ►prbb.org [PDF] M Romero-Gómez, CM Fernández-Rodríguez, … - Journal of Hepatology, 2008 - Elsevier The SVR rate was lower in patients with IFG and/or T2DM than in patients with
normal glucose concentrations [143/325 (44%) vs. 432/734 (58.8%); P = 0.002]. In
the follow-up, abnormal glucose concentrations were observed in 74 of 304 ... Cited by 25 - Related articles - All 20 versions
R Sukhija, WS Aronow, P Kakar, L Garza, R … - The American journal of cardiology, 2006 - Elsevier Microalbuminuria (MA) is a well-known risk factor for coronary artery disease
(CAD) in diabetics and nondiabetics. It is associated with higher cardiovascular
mortality, especially in diabetics. However, there are few data linking ... Cited by 24 - Related articles - All 10 versions
- ►onlinejacc.org [PDF] SH Kim, L Chunawala, R Linde, GM Reaven - Journal of the American College of Cardiology, 2006 - Elsevier The goals of this study were to assess the effect of the 2003 American Diabetes
Association definition of impaired fasting glucose (IFG) on prevalence of IFG,
coronary heart disease (CHD) risk factors, and CHD compared with the 1997 ... Cited by 21 - Related articles - BL Direct - All 23 versions
C Cheng, H Kushner, BE Falkner - Metabolism, 2006 - Elsevier Treatment of prediabetes attenuates progression to type 2 diabetes mellitus. The
American Diabetes Association (ADA) previously defined prediabetes as either
impaired fasting glucose (IFG) = 6.1 to 6.9 mmol/L (110-125 mg/dL) and/or ... Cited by 15 - Related articles - All 8 versions
NG Forouhi, J Luan, S Hennings, NJ … - Diabetic Medicine, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 4 versions
UEA Martensson, SA Salehi, S Windahl, MF … - Endocrinology, 2009 - Endocrine Soc In vitro studies suggest that the G protein-coupled receptor (GPR) 30 is a
functional estrogen receptor. However, the physiological role of GPR30 in vivo
is unknown, and it remains to be determined whether GPR30 is an estrogen ... Cited by 12 - Related articles - All 2 versions
